1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells (1995)
- Authors:
- USP affiliated authors: BRENTANI, MARIA MITZI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM ; FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - HU
- Unidades: FM; HU
- Assunto: RADIOLOGIA
- Language: Inglês
- Imprenta:
- Publisher: Universidade do Chile
- Publisher place: Santiago
- Date published: 1995
- Source:
- Conference titles: Santiago Southern Summer Symposia
-
ABNT
BRENTANI, Maria Mitzi et al. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. 1995, Anais.. Santiago: Universidade do Chile, 1995. . Acesso em: 28 out. 2024. -
APA
Brentani, M. M., Federico, M. H. H., Folgueira, M. A. A. K., & Escaleira, M. T. F. (1995). 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. In Molecular Biology of Cell Differentiation and Embryonic Development. Santiago: Universidade do Chile. -
NLM
Brentani MM, Federico MHH, Folgueira MAAK, Escaleira MTF. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. Molecular Biology of Cell Differentiation and Embryonic Development. 1995 ;[citado 2024 out. 28 ] -
Vancouver
Brentani MM, Federico MHH, Folgueira MAAK, Escaleira MTF. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. Molecular Biology of Cell Differentiation and Embryonic Development. 1995 ;[citado 2024 out. 28 ] - Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma
- Tumor infiltrating lymphocytes express cd 1 b and beta4 integrin chain
- Flow-cytometric dna analysis and hormonal receptor status in brazilian breast cancer patients
- C-ERBB-2 negativo após quimioterapia neoadjuvante (QN) prediz sobrevida livre de doença (SLD) mais longa em pacientes com câncer de mama
- Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer
- Flow-cytometric DNA analysis and hormonal receptor status in brazilian breast cancer patients
- Thymocyte subpopulations and clonality in myasthenia gravis
- Disease free survical in breast cancer with high flowcytometric S phase fraction in Brazilian patients
- Estudo da ploidia e indice proliferativo (fase s) por citometria de fluxo em carcinomas invasivos do colo uterino
- Carboplatina e etoposide (PE) combinados com a vincristina (V)-doxorrubicina (AD)-ciclofosfamida (C) (VADC) no sarcoma de ewing (SE)/tumor neuroectodérmico primitivo (TNEP) em adultos
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
